1. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study. (March 2022) Authors: Baydoun, A.; Chen, H.; Poon, I.; Badellino, S.; Dagan, R.; Erler, D.; Foote, M.C.; Louie, A.V.; Redmond, K.J.; Ricardi, U.; Sahgal, A.; Biswas, T. Journal: Clinical and translational radiation oncology Issue: Volume 33(2022) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes Following Hypofractionated Stereotactic Radiotherapy to the Cavity After Surgery for Melanoma Brain Metastases. Issue 3 (March 2022) Authors: Gallo, J.; Garimall, S.; Shanker, M.; Castelli, J.; Watkins, T.; Olson, S.; Huo, M.; Foote, M.C.; Pinkham, M.B. Journal: Clinical oncology Issue: Volume 34:Issue 3(2022) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery. Issue 1 (January 2019) Authors: Nicholls, L.W.; Pinkham, M.B.; Bernard, A.; Lusk, R.; Watkins, T.; Hall, B.; Olson, S.; Foote, M.C. Journal: Clinical oncology Issue: Volume 31:Issue 1(2019) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗